Literature DB >> 18286449

Potential adverse effects of replacing high volume hemofiltration exchanges on electrolyte balance and acid-base status using the current commercially available replacement solutions in patients with acute renal failure.

A Davenport.   

Abstract

The original substitution and/or dialysates used for continuous hemofiltration and/or dialysis were either based on peritoneal dialysis fluids, or peritoneal dialysates themselves. Although these fluids have been refined over the years, by changing the anionic base from acetate or racemic d+ l-lactate, to bicarbonate or l-lactate, the fluids remain designed for low volume hourly exchanges. Even at relatively low volume exchanges, the composition of these fluids can affect systemic acidbase balance. Those fluids which contain a higher concentration of lactate with a corresponding lower chloride, predispose to a hypochloremic alkalosis, whereas those with a lower concentration of lactate with a corresponding higher chloride potentially lead to a hyperchloremic acidosis. In addition, cation balance, differs when using the same fluid as a replacement solution, compared to dialysate. In particular, sodium balance is greater for post-dilutional fluid replacement, due to the lower sieving coefficient. More recently, citrate has been introduced as an extracorporeal anticoagulant, and a variety of dialysates/replacement fluids have been developed, due to the difference in citrate clearance between dialysis and convection based extracorporeal circuits. Over the last decade, there has been a general increase in the standard hourly dialysate and exchange volumes used in the management of patients with acute kidney injury, from 1 to 2.5-3 l/h. Indeed, even larger volume exchanges, some 6-8 l/h have been advocated to improve patient outcomes. However, before embarking on such continuous high volume exchanges, a new generation of fluids may need to be developed to prevent acid-base and electrolyte imbalances.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18286449     DOI: 10.1177/039139880803100102

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  7 in total

Review 1.  The dark side of high-intensity renal replacement therapy of acute kidney injury in critically ill patients.

Authors:  Helmut Schiffl
Journal:  Int Urol Nephrol       Date:  2010-04-10       Impact factor: 2.370

2.  Dilutional acidosis or uncovered cellular metabolism?

Authors:  Andrew Davenport
Journal:  Intensive Care Med       Date:  2009-10-23       Impact factor: 17.440

Review 3.  Enhancing dialyser clearance-from target to development.

Authors:  Kamonwan Tangvoraphonkchai; Andrew Davenport
Journal:  Pediatr Nephrol       Date:  2017-04-12       Impact factor: 3.714

4.  Application of bedside continuous blood purification in patients with multiple organ dysfunction syndromes.

Authors:  Hai-Bo Liu; Min Zhang; Jing-Xiao Zhang; Yong-Jie Yin
Journal:  World J Emerg Med       Date:  2012

5.  Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit.

Authors:  Andrew Davenport; Ashita Tolwani
Journal:  NDT Plus       Date:  2009-09-25

6.  Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous veno-venous hemofiltration.

Authors:  Rita Jacobs; Patrick M Honore; Marc Diltoer; Herbert D Spapen
Journal:  BMC Nephrol       Date:  2016-08-26       Impact factor: 2.388

7.  Low dialysate sodium levels for chronic haemodialysis.

Authors:  Joanna L Dunlop; Alain C Vandal; Mark R Marshall
Journal:  Cochrane Database Syst Rev       Date:  2019-01-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.